Hu邦 Bio Secures Tens of Millions in Series B+ Equity Financing, Ushering in a New Era of Growth

Recently, Anhui Huibang Bioengineering Co., Ltd. secured tens of millions of yuan in Series B+ equity financing from Chuanggu Capital, an affiliate of Anhui Provincial Investment Group. The funds raised in this round will be used to optimize its industrial chain layout and upgrade its R&D capabilities.

Since its inception, Huibang Bio has been dedicated to precision medicine, adhering to a path of independent innovation. Leveraging its long-standing technological expertise and forward-looking strategic layout, the company has garnered favor and support from multiple investors. Following the completion of its Series B financing by Jiaxing Qihui and Saizhi Capital, and after a year of rapid development, Huibang Bio partnered with Anhui Provincial Investment Group at the end of the year, securing tens of millions of RMB in Series B+ financing from its subsidiary, Chuangu Capital. This brings the total amount raised in the Series B round to RMB 60 million.

With the market launch of Huibang Bio’s series of projects—including quantum dots, flow fluorescence, and chemiluminescence microfluidics—the company is set to enter a new era of development!

On January 5, 2018, Chuanggu Capital was established in the Hefei High-Tech Industrial Development Zone. To implement the “Comprehensive Innovation Reform” plan and meet the requirements for building a provincial-level equity investment fund system, Anhui Provincial Investment Group deepened its pilot reforms as a state-owned capital investment and operating company. Drawing on the successful reform experiences of leading domestic state-owned investment institutions, it initiated the establishment of this market-oriented, professional fund management company through its wholly-owned subsidiary, Anhui High-Tech Industry Investment Co., Ltd., with the management team holding a controlling stake.

We currently manage certain sub-funds under the Provincial “Triple One Innovation” Fund, the Provincial SME (Specialized, Refined, Differential, and Innovative) Fund, and the Provincial Emerging Industries Venture Capital Fund, and have raised and established several fully market-oriented funds.

Chuanggu Capital focuses on key industries such as TMT, big health, cultural tourism, new energy, modern agriculture, equipment manufacturing, and new materials, building a full-lifecycle fund cluster system spanning angel investment, VC, PE, and M&A.